Tazemetostat in Malignant Peripheral Nerve Sheath Tumors
Tazemetostat in Malignant Peripheral Nerve Sheath Tumors
Active, not recruiting · NCT04917042 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tazemetostat in Malignant Peripheral Nerve Sheath Tumors | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Nerve Tissue, Peripheral Nerve Sheath Tumors, connective tissue neoplasm, fibrosarcoma, neoplasm, nerve sheath neoplasm, nervous system disorder, neurofibroma, neurofibrosarcoma, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, sarcoma | Active, not recruiting | Phase 2 | 2026-06-04 | NCT04917042 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Epizyme, Inc. | 8 |
| University of Florida | 315 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Florida | Gainesville | United States | 70 |